Avora

Local Anesthesia in Conjunction with Operative or Surgical Procedures Template

The template

Pick your PMS to format the placeholders, then copy.

Local anesthesia administered.

RMH: Medical history reviewed/updates

Vitals: BP/pulse; other vitals if indicated
ASA: ASA classification if applicable
Consent: Anesthesia consent/PARQ reviewed

Topical applied: Topical anesthetic/application
Location: Location

Anesthetic: Anesthetic used
Carps: Carpules/amount
Technique: Technique

Needle/gauge: Needle gauge/length
Location: Location
Aspiration negative.

Additional injection (if applicable): Additional injection if applicable
Anesthetic: Anesthetic used
Carps: Carpules/amount
Technique: Technique
Location: Location
Aspiration negative.

Total carps: Total carps
Anesthesia achieved.
Patient tolerance: Tolerance/response.

Complications: None or describe.

Documentation requirements

Local anesthesia documentation is a board-and-malpractice issue, not just a billing issue. Charting standard is the same whether D9215 is reimbursed separately or bundled. A defensible D9215 entry must include:

  • Pre-anesthesia medical history review and updated vitals — at minimum BP and pulse before anesthesia is administered. Hypertensive urgency (BP >180/110) is a relative contraindication for vasoconstrictor and a documented concern for any block. Note allergies (especially to amides, sulfites, latex) and current medications (anticoagulants, MAOIs, tricyclics, beta-blockers, recent cocaine use)
  • ASA classification when applicable — ASA I-II routine; ASA III flag for vasoconstrictor dose limits; ASA IV typically defer or refer
  • Topical anesthetic — agent (benzocaine 20%, lidocaine 5%), site, and dwell time before injection
  • Anesthetic agent and concentration — the specific drug and percentage. Common: lidocaine 2%, articaine 4%, bupivacaine 0.5%, mepivacaine 2% or 3% (plain), prilocaine 4%
  • Vasoconstrictor and ratio — epinephrine 1:100,000 or 1:200,000, or levonordefrin 1:20,000, or "plain" (no vasoconstrictor). The ratio is part of the dose calculation and the cardiac-risk justification
  • Volume / carpule count — number of carpules used per site and total. One standard carpule = 1.7-1.8 mL. Total mg dose should stay within the patient's MRD (maximum recommended dose) by weight — this is a board-of-dentistry expectation, especially in pediatrics
  • Technique — infiltration, IAN block, long buccal, lingual, PSA, MSA, ASA, greater palatine, nasopalatine, mental/incisive, Gow-Gates, Vazirani-Akinosi, PDL/intraligamentary, intraosseous, intrapulpal
  • Needle gauge and length — typically 27-gauge long for blocks, 27-gauge or 30-gauge short for infiltrations. Required by some states and by most malpractice carriers' documentation standards
  • Site / location — quadrant, tooth, or anatomic landmark (e.g., "mandibular foramen, right" or "buccal infiltration #3-#4")
  • Aspiration result — "negative" before deposition. Positive aspiration → reposition and re-aspirate before injecting; document this if it occurs
  • Patient response — tolerance, signs of profound anesthesia (lip/tongue numbness for IAN, soft-tissue blanching for infiltration), any adverse events (palpitations, vasovagal, paresthesia, trismus, hematoma)
  • Total carpules administered — single line summary. Critical for MRD calculation and for any post-procedure adverse-event review
  • Complications or none — explicitly state "no complications" or describe the event, intervention, and outcome
  • Operator initials / signature — who administered the anesthetic. In some states, hygienists with an anesthesia permit may administer infiltrations; the operator must be identifiable

For pediatric patients, additionally document weight in kg (not just lb) and confirm the total mg dose is within MRD — Texas, California, and several other state boards specifically audit pediatric anesthetic overdose cases, and articaine in young children is a recurring flag. Do not exceed the manufacturer's MRD even if clinical effect feels insufficient — supplement with technique change (PDL, intraosseous) rather than additional volume.

Common denial reasons

Common reasons D9215 is denied, downcoded, or flagged:

  • Bundled / inclusive in primary procedure — by far the most common EOB message ("included in the procedure fee," "global service," "not separately reimbursable"). This is a policy denial, not a documentation problem.
  • Same-DOS operative or surgical procedure on the claim — automated edit triggers the bundle. Without an operative procedure on the same DOS, D9215 alone may pay on a few plans but is typically denied as "no covered service to associate."
  • Missing technique / agent / volume in documentation if records are requested — when D9215 is the only thing billed (rare scenario) and records are pulled, generic charting like "anesthesia given" fails review
  • Pediatric MRD concerns flagged on audit — total mg dose by weight not documented; articaine in patients under 4 years; lidocaine total approaching toxicity threshold without weight calculation in chart
  • Hygienist-administered anesthesia outside scope — in states permitting hygienist anesthesia, the chart must identify the credentialed operator and note the dentist's authorization; missing operator initials trigger board complaints
  • Multiple D9215 lines on one DOS — submitting D9215 twice for two blocks on the same date will deny the second line; D9215 is once per DOS per provider regardless of injection count
  • Billed with D9210 (now deleted) or other anesthesia codes — D9210 was deleted from CDT and any claim using it will reject; D9211/D9212/D9215 are the current local-anesthesia family but most are still bundled
  • Patient billed for bundled D9215 in a contracted plan — payer audit flag and a patient-complaint generator; verify contract terms before charging the patient

Stop writing local anesthesia notes by hand

Avora listens to the visit and produces a complete, defensible D9215 note in your template — automatically. Copy templates are useful. Avora is faster.

See Avora in action